This is a medicine used to treat conditions like Parkinson's disease or high prolactin levels. It helps control the brain chemical dopamine.
Every report comes from a Lived member, sent anonymously.
Have you tried Bromocriptine for Hyperprolactinemia?
Bromocriptine is a prescription medicine that acts like dopamine, one of the body's chemical messengers. It is sold under two brand names with quite different jobs, and the two are not interchangeable. Parlodel and its generic versions (2.5 mg tablets and 5 mg capsules) are mainly used for conditions caused by too much prolactin, the pituitary hormone that drives breast milk production. High prolactin can stop menstrual periods, cause milky discharge from the nipples, reduce fertility and lower sex hormones in both women and men. A common cause is a prolactinoma, a noncancerous pituitary tumor that makes prolactin. Bromocriptine lowers prolactin and can shrink these tumors, including large ones, and is sometimes used to reduce a tumor before surgery. Cabergoline is another medicine of the same type; in trials comparing the two, cabergoline brought prolactin back to normal and restored regular ovulation more often, with fewer side effects, so the choice between them is worth discussing. Parlodel is also approved for acromegaly, a condition in which a pituitary tumor makes too much growth hormone. Used alone or alongside surgery or radiation, it lowers growth hormone by half or more in about half of people, though usually not to normal levels. In Parkinson's disease it is mainly added to levodopa, the standard Parkinson's medicine that the brain converts into dopamine, for people whose levodopa wears off before the next dose or causes swings in movement, and it may allow a lower levodopa dose. Its benefit beyond two years of use has not been established, and as a first treatment it caused more nausea, hallucinations, confusion and low blood pressure than levodopa did. Cycloset is a low-dose tablet approved for adults with type 2 diabetes, used alongside diet and exercise to lower blood sugar. It is not used for type 1 diabetes. Bromocriptine was once given after childbirth to stop breast milk, but that use was withdrawn because of serious reactions.
Normally, dopamine released from the brain tells the pituitary gland to hold back prolactin. Bromocriptine switches on the same dopamine receptors directly, so the pituitary releases less prolactin. As prolactin falls, periods and ovulation often return, nipple discharge stops and prolactin-producing tumors frequently shrink. In most people with acromegaly it also lowers growth hormone, although that effect is less complete. In Parkinson's disease, the brain cells that make dopamine for movement control are gradually lost. Levodopa has to be converted into dopamine by the cells that remain, whereas bromocriptine stimulates the dopamine receptors in the movement centers of the brain directly. That is why it can smooth out the gaps when levodopa alone is not lasting. For type 2 diabetes, Cycloset taken in the morning is linked to better insulin sensitivity and lower blood sugar after meals, without raising insulin levels. Exactly how it achieves this is not fully understood. Bromocriptine is derived from ergot, a family of compounds that also includes some older migraine medicines, which helps explain several of its interactions and its rare scarring side effects.
Parlodel and generic bromocriptine are taken with food, which reduces nausea and vomiting. The prescriber starts with a small dose and raises it every few days to few weeks, aiming for the lowest dose that works. Doses differ widely by condition: often a few milligrams a day for high prolactin, commonly 20 to 30 mg a day for acromegaly, and slowly built up in divided doses with meals for Parkinson's disease. Blood tests of prolactin or growth hormone guide the adjustments. People with acromegaly who have had pituitary radiation usually take a break of a month or two each year to check whether the medicine is still needed. When bromocriptine is used for high prolactin, fertility can return before periods do. People who are not trying to conceive, and anyone with a large tumor, are advised to use contraception other than birth control pills for as long as they take the medicine. People who want to become pregnant usually use a barrier method, such as condoms, until regular cycles return, and can then stop contraception. In either case, a pregnancy test is advised about every four weeks while periods are absent, and again whenever a period is late. Treatment is usually stopped once pregnancy is confirmed, so a positive test should be reported to the prescriber promptly. Cycloset is taken once a day within two hours of waking, with food. It starts at one 0.8 mg tablet and goes up by one tablet each week to between 1.6 mg and 4.8 mg a day, depending on what is tolerated. A missed morning dose is skipped, and the usual dose is taken the next morning rather than doubled.
Nausea is the most common side effect, affecting about half of people treated for high prolactin and about a third of those taking Cycloset. Headache, dizziness, tiredness, vomiting, constipation and a stuffy nose are also common. These are most noticeable when starting or raising the dose and often settle; with Cycloset they typically lasted about two weeks. Low blood sugar is more likely when Cycloset is added to a sulfonylurea (a type of diabetes pill that makes the pancreas release more insulin) or to insulin, so those doses may need adjusting. Bromocriptine can lower blood pressure, especially when standing up, during the first days of treatment and after dose increases. This can cause lightheadedness or fainting, more often in people who also take blood pressure medicines. Standing up slowly helps. Some people become very sleepy or fall asleep suddenly during daily activities, sometimes without warning, particularly those with Parkinson's disease. Anyone who has had this should not drive or operate machinery and should tell the prescriber, since a lower dose or a different medicine may be needed. Like other dopamine-boosting medicines, bromocriptine can cause new or stronger urges to gamble, spend money or have sex that are hard to control. People often don't recognize the change themselves, so family members may notice first; it should be reported, because the urges often ease with a lower dose or stopping. Hallucinations and confusion can occur, mostly at higher doses and in people with Parkinson's disease, and usually improve when the dose is reduced. Long-term, high-dose use has rarely been linked to scarring (fibrosis) of the linings around the lungs and heart, of heart valves, and of the tissue at the back of the abdomen. Unexplained shortness of breath, ongoing back pain, leg swelling or reduced kidney function should be checked. People with large prolactinomas, especially after pituitary surgery or radiation, should report a persistent clear, watery drip from the nose, which can be leaking brain fluid. In acromegaly, fingers may turn pale in the cold; keeping hands warm and a lower dose usually help.
Bromocriptine is not used by people with an allergy to it or to other ergot medicines, and Parlodel and generic bromocriptine are not used with uncontrolled high blood pressure. Cycloset is also not used by people who have migraines that cause fainting. Neither product is used while breastfeeding after delivery, and Cycloset is not used in the period after childbirth. Starting or restarting Parlodel after giving birth, for example for a prolactinoma, needs a specific discussion with the prescriber first, especially for anyone with heart disease. That caution exists because in women given bromocriptine after childbirth, serious high blood pressure, seizures, strokes and heart attacks have been reported, often preceded by a constant headache that worsened over hours to days, sometimes with blurred vision. For anyone taking bromocriptine, high blood pressure readings or a severe, worsening or unrelenting headache, with or without vision changes, should be reported to the prescriber right away; the medicine is usually stopped while this is evaluated. Antipsychotic medicines and metoclopramide (a medicine for nausea and reflux) block dopamine, so they and bromocriptine weaken each other; combining them is generally not recommended, and bromocriptine can worsen severe psychotic illness. Certain antifungal pills (the azole type, such as ketoconazole), some HIV medicines and the antibiotic erythromycin slow the liver's breakdown of bromocriptine and can raise its levels several-fold; Cycloset's dose is capped or the combination avoided. Ergot migraine medicines such as ergotamine are not combined with it, and triptan migraine medicines such as sumatriptan are avoided with Cycloset. Blood pressure medicines add to the risk of dizziness, alcohol can make side effects worse, and Cycloset is not recommended alongside other dopamine-type medicines. For pregnancy, the manufacturer's records of more than 1,000 pregnancies in which bromocriptine was taken, mostly only in the first weeks, did not suggest a higher rate of birth defects than in the general population. The bigger concern is the tumor: a prolactinoma can grow during pregnancy and press on the nerves to the eyes, so pregnant people with these tumors are watched closely, and new headaches or worsening vision should be reported promptly. If bromocriptine is continued or restarted during pregnancy, high blood pressure or signs of preeclampsia (a pregnancy condition marked by high blood pressure) are a reason to review it with the prescriber right away.
Side effects tend to come first and ease over the following weeks, which is why doses are raised slowly. For high prolactin and acromegaly, progress is measured with repeat hormone blood tests, and the dose is adjusted until levels respond. People with large prolactinomas usually have regular vision checks, including testing of side vision, because the tumor can affect the nerves to the eyes; occasionally, vision can worsen even as the tumor shrinks, and this calls for prompt review. For type 2 diabetes, Cycloset's effect is modest. In 24-week trials, A1C (a blood test reflecting average blood sugar over about three months) fell by roughly 0.4 to 0.6 percentage points more than with a placebo, and weight changed little. In the longest trial, nearly half of people taking it stopped early, more than with placebo, so tolerability is a real part of the decision. Stopping should be planned with the prescriber. With a large prolactinoma, stopping often lets the tumor regrow quickly and prolactin rise again, so treatment can be long-term. In Parkinson's disease, the dose is reduced gradually: sudden stopping or big dose changes have rarely triggered a serious reaction with high fever, rigid muscles and confusion, and some people get withdrawal symptoms such as apathy, anxiety, low mood, sweating and pain. Long-term use also brings periodic blood tests to check the liver, kidneys and blood counts. Regular skin checks are advised for anyone taking bromocriptine, because melanoma, a serious skin cancer, is more common in people with Parkinson's disease.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Bromocriptine, what you've noticed, or ask the community a question.